药物开发 药物开发
Ralph Kern1, Lily Lee1, Robbert Zusterzeel1
1Cognito Therapeutics, Cambridge, MA, USA.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
这项研究探讨了SpectrisTM,这是一种用于阿尔茨海默病的家庭视听神经调节装置. 早期结果表明,它可能为患者提供安全有效的治疗选择.
科学领域:
- 神经调节是一种神经调节.
- 神经退行性疾病 神经退行性疾病
- 阿尔茨海默病的治疗方法 治疗方法
背景情况:
- 阿尔茨海默病 (AD) 呈现出一个重要的未满足的医疗需求.
- 康尼托疗法公司正在开发SpectrisTM,这是一个非侵入性,在家用,用于AD的视听神经调节装置.
- 该设备旨在改变轻度至中度阿尔茨海默病的生物和临床进展.
研究的目的:
- 评估SpectrisTM在患有轻度至中度阿尔茨海默病的参与者中的安全性和有效性.
- 讨论SpectrisTM对患者,家庭和医疗保健系统的潜在影响.
- 提供关于在家神经调节用于AD管理的见解.
主要方法:
- OVERTURE试验是一项随机对照试验 (RCT),具有开放标签扩展 (OLE).
- 参与者每天接受一个小时的活跃或虚假治疗,持续6个月.
- 目前正在进行的HOPE试验是一项为期12个月的RCT与12个月的OLE评估SpectrisTM在轻度至中度AD.
主要成果:
- 将介绍来自OVERTURE RCT和OLE的临床和MRI生物标志物结果.
- 对OVERTURE和HOPE研究设计和基线特征进行比较.
- 评估每日在家进行的非侵入性神经调节疗法的关键见解.
结论:
- SpectrisTM显示出作为阿尔茨海默病的安全,有效和具有成本效益的治疗潜力.
- 该设备可能会为患有轻度至中度AD的个体扩大治疗选择.
- 在家中神经调节为管理阿尔茨海默病提供了一种方便的方法.
更多相关视频
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
3.3K
05:45Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
Published on: October 10, 2025
451
相关概念视频
Preclinical Development: Overview
5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation
279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
